ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,771Medicare Part D Prescriptions Filled, Including Refills

Rank: 301 out of 6645

$627K Total Retail Price of All Prescriptions

Rank: 781 out of 6645

732 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 732 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 14,413 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LISINOPRIL 1,240 1,147 1 3
SIMVASTATIN 1,064 962 2 1
METFORMIN HCL 1,063 956 3 7
OMEPRAZOLE 802 737 4 6
LEVOTHYROXINE SODIUM 599 545 5 4
CARVEDILOL 502 446 6 25
ALENDRONATE SODIUM 410 408 7 14
TAMSULOSIN HCL 354 334 8 22
GLIMEPIRIDE 345 286 9 47
BENAZEPRIL HCL 334 298 10 21
HYDROCHLOROTHIAZIDE 318 306 11 9
FUROSEMIDE 300 284 12 11
PRAVASTATIN SODIUM 284 250 13 20
IBUPROFEN 245 222 14 42
VYTORIN 244 230 15 170
LOSARTAN POTASSIUM 237 229 16 12
INDAPAMIDE 235 225 17 378
AMLODIPINE BESYLATE 211 199 18 2
ATORVASTATIN CALCIUM 199 187 19 10
LOVASTATIN 195 184 20 15
JANUVIA 188 150 21 38
ATENOLOL 185 178 22 8
DICLOFENAC SODIUM 164 132 23 109
METOPROLOL TARTRATE 160 150 24 13
ZOLPIDEM TARTRATE 139 121 25 17
HUMALOG MIX 75-25 129 126 26 357
INSULIN SYRINGE 124 119 27 61
NAPROXEN 123 108 28 88
PANTOPRAZOLE SODIUM 119 109 29 29
GABAPENTIN 115 95 30 18
CLOTRIMAZOLE-BETAMETHASONE 112 96 31 177
SERTRALINE HCL 106 103 32 43
NAMENDA 103 103 33 41
ACTOS 102 82 34 71
HYDROCODONE-ACETAMINOPHEN 100 85 S3 35 5
DIOVAN 100 96 35 19
WARFARIN SODIUM 99 94 37 16
FELODIPINE ER 98 92 38 105
JANUMET 97 95 39 132
DILTIAZEM 24HR ER 87 87 40 187
GLIPIZIDE 86 78 41 23
DONEPEZIL HCL 86 85 41 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 76 43 37
CLOPIDOGREL 85 77 43 36
DIOVAN HCT 83 83 45 64
AZITHROMYCIN 82 68 46 44
CEPHALEXIN 80 72 47 111
DILTIAZEM ER 79 69 48 182
ETODOLAC 75 72 49 283
HUMALOG 74 66 50 137
DOXAZOSIN MESYLATE 70 70 51 81
PLAVIX 70 62 51 49
PROAIR HFA 63 62 53 32
METOPROLOL SUCCINATE 61 61 54 24
PAROXETINE HCL 60 52 55 72
ALLOPURINOL 58 52 56 31
ISOSORBIDE MONONITRATE ER 58 58 56 66
TRAMADOL HCL 56 44 58 30
FLUTICASONE PROPIONATE 56 54 58 26
FLUOXETINE HCL 55 34 60 63
ADVAIR DISKUS 54 52 61 45
CLONIDINE HCL 54 53 61 56
LIPITOR 52 47 63 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 26, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.